OMICS International Organises 3000+ Global Conferenceseries Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
For more Conferences visit www.conferenceseries.com

Back

Enzi Jiang

Enzi Jiang

University of Southern California

Research Associate

Biography

Dr. Enzi (Eun Ji) Jiang (Gang) received her M.D. from Norman Bethune College of Medicine, Jilin University, formerly Norman Bethune University of Medical Science, Changchun, China in 1987. She has completed her Ph.D. from Harbin Medical University in 1999 and postdoctoral studies from University of Texas Southwestern Medical Center at Dallas in 2007. Dr. Jiang is working as a senior scientist at Division of Hematology and Oncology, Children’s Hospital Los Angeles University of Southern California Keck School of Medicine, Los Angeles, USA. She has published more than 15 papers in reputed journals related to mesenchymal stem cells and leukemia and contributed to a book chapter (Chapter 4: Molecular Pathogenesis of ALL, Contemporary Management of Acute Lymphoblastic Leukemia, In Press 2013). Dr. Jiang is serving as an editorial board member for the Journal of Blood Disorders and Transfusion. Her research interests include: mouse models of pre-B acute lymphoblastic leukemia and its application in preclinical evaluation of novel anticancer therapy, stem cell niches, integrins, survivin, drug resistance, minimal residual disease, small molecule inhibitors of Wnt signaling pathway, mesenchymal stem cells isolation and application in regenerative medicine such as muscular dystrophy

Research

Dr. Enzi Jiang research is on Mouse models of pre-B acute lymphoblastic leukemia and its application in preclinical evaluation of novel anticancer therapy, stem cell niches, integrins, survivin, drug resistance, minimal residual disease, small molecule inhibitors of Wnt signaling pathway, mesenchymal stem cells isolation and application in regenerative medicine such as muscular dystrophy.